+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Merit Medical Systems Inc (MMSI) - Product Pipeline Analysis, 2022 Update

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Merit Medical Systems Inc (Merit Medical) is a medical devices company offering a range of single-use medical products for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic catheters and fluid dispensing systems, and embolotherapy products. Merit Medical’s products find applications in various diagnostic and interventional cardiology fields including radiology, cardiology and endoscopy and other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, oncology and pain management. It markets its products through direct sales force in the US and Western Europe, and China; and through independent dealer organizations and network of OEM partners in the Americas, Europe, Africa, the Middle East, Asia and Oceania. Merit Medical is headquartered in South Jordan, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Merit Medical Systems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Merit Medical Systems Inc Company Overview
  • Merit Medical Systems Inc Company Snapshot
  • Merit Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Merit Medical Systems Inc - Pipeline Analysis Overview
  • Business Descriptio

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Co
  • Abbott Laboratories
  • AngioDynamics Inc
  • Argon Medical Devices Inc
  • B. Braun Melsungen AG
  • Becton Dickinson and Co
  • Boston Scientific Corp
  • ConMed Corp
  • Cook Group Inc
  • Cordis Corp
  • Edwards Lifesciences Corp
  • Getinge AB
  • Guerbet SA
  • ICU Medical Inc
  • Johnson & Johnson
  • Medical Components Inc
  • Medtronic Plc
  • Olympus Corp
  • Stryker Corp
  • Teleflex Inc
  • Terumo Corp
  • United States Endoscopy Group Inc
  • UreSil LLC